Taysha Gene Therapies Inc Cash Flow Quality Index
Taysha Gene Therapies Inc cash flow quality index. Taysha Gene Therapies Inc (TSHA) has a Cash Flow Quality Index of -0.34x as of December 2023. Operating cash flow of $-16.12 Million is below net income of $47.74 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of Taysha Gene Therapies Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Taysha Gene Therapies Inc Cash Flow Quality Index by Year (None–None)
Taysha Gene Therapies Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Taysha Gene Therapies Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Taysha Gene Therapies Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|